This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In the United States, the increasing cost of health care continues to be a serious medical, personal, and financial crisis for patients, doctors, and hospitals, as well as for businesses, insurers, and the government.1 On the therapeutic side, it is becoming commonplace for some new pharmaceuticals to cost tens to hundreds of thousands of dollars a year. On the diagnostic side, advanced imaging, especially MRI, is increasingly used. Although highly efficacious, its use is also driving up health care costs. These high costs have resulted in an increasing bureaucracy of insurance regulations, denials, appeals, and peer reviews. The increasing cost of health care has put the focus on value. Because value is defined as quality divided by cost, a test such as MRI, which has a high quality but also a high cost, has its value limited to certain situations. What one ideally wants in a diagnostic test is high quality and low cost. Neuromuscular ultrasound (NMUS) is such a diagnostic test whose time has come. In this issue of Neurology®, Mandeville et al.2 report the robust cost-effectiveness of NMUS used in addition to electrodiagnostic testing in focal neuropathies.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
See page 1087
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
